eCite Digital Repository

The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives

Citation

Mahmood, MQ and Shukla, SD and Dua, K and Shastri, MD, The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives, Current Pharmaceutical Design, 23, (16) pp. 2314. ISSN 1381-6128 (2018) [Review Several Works]


Preview
PDF
Not available
2Mb
  

DOI: doi:10.2174/1381612823666170124115159

Abstract

Background: The global burden of gastrointestinal cancers, including colorectal, stomach, and esophageal cancers is rising steadily. Several therapeutic approaches have been considered for the treatment of GI carcinomas. However, none showed to halt or cure the disease. There is a need to develop effective targeted molecular therapies; mainly to overcome the adverse effects of currently used treatment regimens, as well as, to benefit a large proportion of cancer patients who do not respond well to chemotherapeutics.

Methods: Epidermal growth factor receptor (EGFR) is one of the promising targets for cancer therapy. Through a cascade of events, activation of EGFR plays an important role in the homeostasis and pathogenesis of various disorders, including carcinomas of the gastrointestinal (GI) tract, ranging from oesophagitis to complex colon carcinoma.

Results: The GI carcinomas are associated with aberrant EGFR expression. In this review, emphasis was made on various EFGR-associated signalling pathways, their mechanisms and role in the formation of gastrointestinal lesions.

Conclusion: The current EGFR-targeting therapeutics and an outline of various novel drug delivery systems that could potentially be employed for targeting EGFR during cancer treatment were discussed. This would help medical, pharmaceutical and other life science researchers in providing broad understanding of the work previously conducted in this field.

Item Details

Item Type:Review Several Works
Keywords:EGFR, Chemotherapeutics, Gastrointestinal carcinoma
Research Division:Medical and Health Sciences
Research Group:Clinical Sciences
Research Field:Gastroenterology and Hepatology
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Cancer and Related Disorders
UTAS Author:Mahmood, MQ (Mr Malik Mahmood)
UTAS Author:Shukla, SD (Mr Shakti Shukla)
UTAS Author:Shastri, MD (Mr Madhur Shastri)
ID Code:129484
Year Published:2018
Web of Science® Times Cited:3
Deposited By:Medicine
Deposited On:2018-12-03
Last Modified:2018-12-18
Downloads:0

Repository Staff Only: item control page